From theheart.org on Medscape

Coverage from the

Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2021

May 18 - 20, 2021; Virtual

May 18 - 20, 2021 Virtual
  • EuroPCR 2021 PASCAL Mitral Valve Repair Shines at 2 Years in CLASP Follow-up is still ongoing but existing data show sustained favorable outcomes for the system -- already approved in Europe and the subject of an ongoing pivotal US trial.

Conference News

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

News from EuroPCR 2020

  • ORBITA: FFR/iFR Predict Ischemia but Not Symptoms After PCI ORBITA: FFR/iFR Predict Ischemia but Not Symptoms After PCI New results from the controversial trial suggest invasive physiology predicts ischemia after intervention, but not angina or exercise time, indicating their relationship with PCI might be more complex, researchers say.
  • SPYRAL HTN-ON MED Gives Traction to Renal Denervation Field SPYRAL HTN-ON MED Gives Traction to Renal Denervation Field Although not the definitive answer, the trial adds to a changing body of evidence suggesting that renal denervation to lower blood pressure 'seems to be back,' observers say.
  • Cath Lab Radiation Shielding Protects Whole Team Cath Lab Radiation Shielding Protects Whole Team A model of radiation exposure in the cath lab shows that most of the scatter comes from under the table, and a new system may cut the risk for exposure compared with standard shielding.